Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Godman

Showing results (461-470 of 479) with videos related to

Pageof 48
Sort By:
Antibiotics (Basel, Switzerland)|January 21, 2022
Management of Children Admitted to Hospitals across Bangladesh with Suspected or Confirmed COVID-19 and the Implications for the Future: A Nationwide Cross-Sectional StudyKona Chowdhury, Mainul Haque, Nadia Nusrat, et al.
Frontiers in Pharmacology|April 11, 2020
Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and ImplicationsNenad Miljković, Brian Godman, Milena Kovačević, et al.
Current Medical Research and Opinion|December 4, 2019
Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the futureBrian Godman, Mainul Haque, Judy McKimm, et al.
Expert Review of Clinical Pharmacology|December 10, 2014
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Brian Godman, Rickard E Malmström, Eduardo Diogene, et al.
Biomed Research International|October 22, 2021
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and ImplicationsBrian Godman, Magdalene Wladysiuk, Stuart McTaggart, et al.
Frontiers in Pharmacology|August 13, 2016
Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the FutureWinnie de Bruijn, Cristina Ibáñez, Pia Frisk, et al.
Frontiers in Pharmacology|September 8, 2017
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential ImplementationPatricia Vella Bonanno, Michael Ermisch, Brian Godman, et al.
Biomed Research International|April 17, 2023
Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications"Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, et al.
Frontiers in Pharmacology|February 7, 2018
Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian CountriesTomasz Bochenek, Vafa Abilova, Ali Alkan, et al.
Pharmacoeconomics|August 1, 2020
Integrative Review of Managed Entry Agreements: Chances and LimitationsCarolina Zampirolli Dias, Brian Godman, Ludmila Peres Gargano, et al.
Pageof 48

Showing results (461-470 of 479) with videos related to

Sort By:
Pageof 48
Antibiotics (Basel, Switzerland)|January 21, 2022
Management of Children Admitted to Hospitals across Bangladesh with Suspected or Confirmed COVID-19 and the Implications for the Future: A Nationwide Cross-Sectional StudyKona Chowdhury, Mainul Haque, Nadia Nusrat, et al.
Frontiers in Pharmacology|April 11, 2020
Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and ImplicationsNenad Miljković, Brian Godman, Milena Kovačević, et al.
Current Medical Research and Opinion|December 4, 2019
Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the futureBrian Godman, Mainul Haque, Judy McKimm, et al.
Expert Review of Clinical Pharmacology|December 10, 2014
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Brian Godman, Rickard E Malmström, Eduardo Diogene, et al.
Biomed Research International|October 22, 2021
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and ImplicationsBrian Godman, Magdalene Wladysiuk, Stuart McTaggart, et al.
Frontiers in Pharmacology|August 13, 2016
Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the FutureWinnie de Bruijn, Cristina Ibáñez, Pia Frisk, et al.
Frontiers in Pharmacology|September 8, 2017
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential ImplementationPatricia Vella Bonanno, Michael Ermisch, Brian Godman, et al.
Biomed Research International|April 17, 2023
Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications"Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, et al.
Frontiers in Pharmacology|February 7, 2018
Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian CountriesTomasz Bochenek, Vafa Abilova, Ali Alkan, et al.
Pharmacoeconomics|August 1, 2020
Integrative Review of Managed Entry Agreements: Chances and LimitationsCarolina Zampirolli Dias, Brian Godman, Ludmila Peres Gargano, et al.
Pageof 48